We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$20M
3
PLTR icon
Palantir
PLTR
+$18.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.7M
5
DEO icon
Diageo
DEO
+$16.3M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLYVK icon
3301
Liberty Live Group Series C
LLYVK
$9.92B
$34.3K ﹤0.01%
422
-4,141
-91% -$305K
ADCT icon
3302
ADC Therapeutics
ADCT
$134M
$34.2K ﹤0.01%
12,779
+2,645
+26% +$5.56K
MAMA icon
3303
Mama's Creations
MAMA
$790M
$34.2K ﹤0.01%
4,126
+1,808
+78% +$13K
ARDT
3304
Ardent Health
ARDT
$1.55B
$34.2K ﹤0.01%
2,507
+1,462
+140% +$19.7K
HOFT icon
3305
Hooker Furnishings Corp
HOFT
$158M
$34.1K ﹤0.01%
3,223
+2,354
+271% +$22.7K
OLMA icon
3306
Olema Pharmaceuticals
OLMA
$920M
$34.1K ﹤0.01%
8,004
+2,610
+48% +$11.6K
DAWN
3307
DELISTED
Day One Biopharmaceuticals
DAWN
$34.1K ﹤0.01%
5,244
+3,326
+173% +$22.9K
UAMY icon
3308
United States Antimony
UAMY
$799M
$33.9K ﹤0.01%
15,569
+14,979
+2,539% +$42.4K
UA icon
3309
Under Armour Class C
UA
$2.25B
$33.9K ﹤0.01%
5,226
-1,091
-17% -$6.44K
SLS icon
3310
SELLAS Life Sciences
SLS
$2.5B
$33.9K ﹤0.01%
15,465
-5,424
-26% -$8.32K
FLWS icon
3311
1-800-Flowers.com
FLWS
$261M
$33.8K ﹤0.01%
6,878
+164
+2% +$849
KRRO icon
3312
Korro Bio
KRRO
$196M
$33.8K ﹤0.01%
2,709
+1,945
+255% +$28K
NKTX icon
3313
Nkarta
NKTX
$165M
$33.8K ﹤0.01%
20,359
+10,073
+98% +$18.5K
SBS icon
3314
Sabesp
SBS
$16.5B
$33.8K ﹤0.01%
+7,931
New +$30.7K
SSKN
3315
DELISTED
Strata Skin Sciences
SSKN
$33.8K ﹤0.01%
14,741
+12,963
+729% +$32.4K
LEN.B icon
3316
Lennar Class B
LEN.B
$20.7B
$33.7K ﹤0.01%
320
+220
+220% +$22.7K
UNTY icon
3317
Unity Bancorp
UNTY
$620M
$33.6K ﹤0.01%
713
-552
-44% -$23.8K
UPB
3318
Upstream Bio Inc
UPB
$378M
$33.5K ﹤0.01%
3,051
+1,469
+93% +$13.6K
KYTX icon
3319
Kyverna Therapeutics
KYTX
$500M
$33.5K ﹤0.01%
10,906
+2,733
+33% +$6.76K
ARCT icon
3320
Arcturus Therapeutics
ARCT
$223M
$33.4K ﹤0.01%
2,571
-3,905
-60% -$46.2K
GRFS
3321
Grifois
GRFS
$5.4B
$33.4K ﹤0.01%
3,700
-5,483
-60% -$42.8K
WOW
3322
DELISTED
WideOpenWest
WOW
$33.4K ﹤0.01%
8,228
+6,439
+360% +$27.6K
BOC icon
3323
Boston Omaha
BOC
$431M
$33.4K ﹤0.01%
2,377
+1,177
+98% +$17.1K
CRBP icon
3324
Corbus Pharmaceuticals
CRBP
$195M
$33.3K ﹤0.01%
4,833
+2,002
+71% +$14.5K
STKS icon
3325
The ONE Group
STKS
$56.8M
$33.3K ﹤0.01%
8,232
+4,776
+138% +$16.4K
131 132
133
134 135

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.